Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Document type

Article

Version

Published version

Publication date

Publication license

cc-by-nc (c) Oller et al., 2016
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/118849

Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Brain delivery is one of the major challenges in drug development because of the high number of patients suffering from neural diseases and the low efficiency of the treatments available. Although the blood-brain barrier (BBB) prevents most drugs from reaching their targets, molecular vectors - known as BBB shuttles - offer great promise to safely overcome this formidable obstacle. In recent years, peptide shuttles have received growing attention because of their lower cost, reduced immunogenicity, and higher chemical versatility than traditional Trojan horse antibodies and other proteins.

Citation

Citation

OLLER SALVIA, Benjamí, et al. Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery. Chemical Society Reviews. 2016. Vol. 45, num. 17, pags. 4690-4707. ISSN 0306-0012. [consulted: 18 of August of 2026]. Available at: https://hdl.handle.net/2445/118849

Export metadata

JSON - METS

Share record